Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 1
Out of 4,966 analysts
131
Total ratings
68.48%
Success rate
165.02%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Buy | $435 → $385 | $301.80 | +27.57% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $125.66 | +23.35% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $129.49 | -38.22% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $28.69 | +53.36% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,301.04 | -15.45% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $205.82 | +26.32% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $277.99 | +4.32% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $8.78 | +150.57% | 1 | Dec 10, 2024 | |
| DGX Quest Diagnostics | Assumes: Buy | $185 | $181.64 | +1.85% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $67.12 | +26.64% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $43 → $56 | $46.50 | +19.61% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $26.97 | +29.77% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $90.11 | +38.72% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $14.01 | +71.31% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.31 | +205.34% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $0.68 | +341.18% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $168.25 | -15.60% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $67.42 | -52.54% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $99.96 | +15.05% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $6.37 | +213.97% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $492.72 | +31.92% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $16.37 | -45.02% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.41 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.05 | +485.37% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $4.55 | +1,218.68% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $3.46 | +564.74% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $163.31 | +138.81% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.31 | +443.81% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $473.30 | -57.74% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $21.18 | +13.31% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $14.30 | +214.69% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $122.32 | -42.77% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $190.81 | -37.11% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.52 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $33.98 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $14.01 | +292.58% | 1 | Jul 19, 2016 |
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $301.80
Upside: +27.57%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $125.66
Upside: +23.35%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $129.49
Upside: -38.22%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $28.69
Upside: +53.36%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,301.04
Upside: -15.45%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $205.82
Upside: +26.32%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $277.99
Upside: +4.32%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $8.78
Upside: +150.57%
Quest Diagnostics
Dec 10, 2024
Assumes: Buy
Price Target: $185
Current: $181.64
Upside: +1.85%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $67.12
Upside: +26.64%
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $46.50
Upside: +19.61%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $26.97
Upside: +29.77%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $90.11
Upside: +38.72%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $14.01
Upside: +71.31%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.31
Upside: +205.34%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $0.68
Upside: +341.18%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $168.25
Upside: -15.60%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $67.42
Upside: -52.54%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $99.96
Upside: +15.05%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $6.37
Upside: +213.97%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $492.72
Upside: +31.92%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $16.37
Upside: -45.02%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.41
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.05
Upside: +485.37%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $4.55
Upside: +1,218.68%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $3.46
Upside: +564.74%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $163.31
Upside: +138.81%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.31
Upside: +443.81%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $473.30
Upside: -57.74%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $21.18
Upside: +13.31%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $14.30
Upside: +214.69%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $122.32
Upside: -42.77%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $190.81
Upside: -37.11%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.52
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $33.98
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $14.01
Upside: +292.58%